WallStreetZenWallStreetZen

NASDAQ: TCRX
Tscan Therapeutics Inc Stock Ownership - Who owns Tscan Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Tscan Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Timothy J. BarberichDirector2023-12-19317$4.97
$1.57kBuy
Timothy J. BarberichDirector2023-12-1828,830$4.89
$140.89kBuy
Barbara KlenckeDirector2023-12-145,000$5.08
$25.40kBuy
Timothy J. BarberichDirector2023-06-0237,880$2.63
$99.55kBuy
Lynx1 Capital Management LP10% Owner2023-05-31400$2.51
$1.00kSell
Lynx1 Capital Management LP10% Owner2023-05-3115,000$2.52
$37.80kSell
Lynx1 Capital Management LP10% Owner2023-05-3110,000$2.52
$25.15kSell

1 of 1

TCRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TCRX insiders and whales buy or sell their stock.

TCRX Shareholders

What type of owners hold Tscan Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Lynx1 Capital Management LP10.96%5,250,000$36.33MInsider
Lynx1 Capital Management LP10.91%5,224,600$36.15MInstitution
Ecor1 Capital LLC10.44%5,000,000$34.60MInsider
Ecor1 Capital LLC10.44%5,000,000$34.60MInstitution
Adage Capital Partners GP LLC8.14%3,900,000$26.99MInstitution
Bvf Inc6.24%2,989,474$20.69MInstitution
Baker Bros Advisors LP5.82%2,784,792$19.27MInstitution
Baker Bros Advisors LP5.28%2,528,583$17.50MInsider
Propel Bio Management LLC4.36%2,087,139$14.44MInstitution
Vanguard Group Inc3.73%1,788,152$12.37MInstitution

1 of 3

TCRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TCRX66.65%29.73%Net Buying
MGTX51.67%48.33%Net Buying
JSPR60.15%39.85%Net BuyingNet Buying
SLDB21.64%78.36%Net BuyingNet Selling
PGEN25.15%73.06%Net BuyingNet Selling
View Top Biotech Stocks

Tscan Therapeutics Stock Ownership FAQ

Who owns Tscan Therapeutics?

Tscan Therapeutics (NASDAQ: TCRX) is owned by 66.65% institutional shareholders, 29.73% Tscan Therapeutics insiders, and 3.62% retail investors. Lynx1 Capital Management LP is the largest individual Tscan Therapeutics shareholder, owning 5.25M shares representing 10.96% of the company. Lynx1 Capital Management LP's Tscan Therapeutics shares are currently valued at $35.81M.

If you're new to stock investing, here's how to buy Tscan Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.